# DunedinPACE Epigenetic Clock Speedometer - Clinical Longevity Review & Consensus Audit

> **Consensus Verdict**: DunedinPACE (Pace of Aging, Computed from the Epigenome) is a third-generation blood DNA methylation biomarker developed by Belsky, Caspi, and Moffitt from the longitudinal Dunedin Study cohort. Unlike first-generation (Horvath, Hannum) and second-generation (PhenoAge, GrimAge) clocks which measure biological age as a static odometer, DunedinPACE functions as an instantaneous speedometer—quantifying the biological pace of deterioration per chronological year across 19 multi-organ physiological biomarkers. A DunedinPACE score of 1.0 indicates aging at the expected chronological pace, whereas scores below 0.8 indicate a decelerated pace of aging associated with markedly lower morbidity and mortality.

## 1. Executive Summary & Scores
- **Longevity Evidence Score**: **97/100**
- **Evidence Quality Tier**: **gold**
- **Human Clinical Evidence Strength**: 98/100
- **Primary Longevity Classification**: other
- **Safety Margin Score**: 99/100 (Higher is safer)
- **Time Burden**: ~1 minutes/day
- **Estimated Monthly Cost**: inexpensive
- **Adherence Friction**: 2/10 (Lower is easier to sustain)

---

## 2. Biological Mechanisms of Action
Quantifies systemic physiological decline across 19 organ system biomarkers tracked over 4 decades, providing the most responsive biomarker of pace of aging available.

---

## 3. Canonical Longevity Vector Impacts (The 8 Longevity Pillars)
- **Heart Health & Endothelial Function**: **0/100** [Rank #122 of 133 in Heart] - Effect: Surveillance Only
    - Mechanism: Diagnostic surveillance tool; quantifies objective biomarkers and anatomical status for heart health without directly inducing biochemical adaptation.
- **Brain Longevity & Neuroprotection**: **0/100** [Rank #130 of 141 in Brain] - Effect: Surveillance Only
    - Mechanism: Diagnostic surveillance tool; quantifies objective biomarkers and anatomical status for brain longevity without directly inducing biochemical adaptation.
- **Metabolic Flexibility & Glycemic Control**: **0/100** [Rank #110 of 129 in Metabolic] - Effect: Surveillance Only
    - Mechanism: Diagnostic surveillance tool; quantifies objective biomarkers and anatomical status for metabolic health without directly inducing biochemical adaptation.
- **Cancer Defense & DNA Repair**: **0/100** [Rank #90 of 120 in Cancer Defense] - Effect: Surveillance Only
    - Mechanism: Diagnostic surveillance tool; quantifies objective biomarkers and anatomical status for cancer defense without directly inducing biochemical adaptation.
- **Endocrine & Anabolic Balance**: **0/100** [Rank #70 of 120 in Endocrine] - Effect: Neutral
    - Mechanism: Epigenetic methylation assay; diagnostic readout without steroidogenic stimulation.
- **Chronic Inflammation Reduction**: **0/100** [Rank #119 of 126 in Inflammation] - Effect: Surveillance Only
    - Mechanism: Diagnostic surveillance tool; quantifies objective biomarkers and anatomical status for chronic inflammation without directly inducing biochemical adaptation.
- **Bone Density & Connective Matrix**: **0/100** [Rank #104 of 142 in Bone Matrix] - Effect: Surveillance Only
    - Mechanism: Diagnostic surveillance tool; quantifies objective biomarkers and anatomical status for bone density without directly inducing biochemical adaptation.
- **Cellular Longevity & Autophagy**: **0/100** [Rank #125 of 131 in Cellular] - Effect: Surveillance Only
    - Mechanism: Diagnostic surveillance tool; quantifies objective biomarkers and anatomical status for cellular longevity without directly inducing biochemical adaptation.

---

## 4. Practical Protocol & Administration Guidelines
- **Standard Clinical Dosage**: Standard dose
- **Recommended Timing**: Morning / With Meal (8:00 AM - 10:00 AM)
- **Administration Type**: Behavioral / Compound
- **Recommended Biomarkers to Monitor**: cellular_longevity, calmness, bone_density, heart_health, testosterone, cancer_defense

---

## 5. Safety, Contraindications & Drug Interactions
- **Contraindications**: Active hematologic malignancy or bone marrow transplantation (distorts blood DNA methylation signature), Severe acute systemic sepsis or recent blood transfusion within 48 hours
- **Safety Profile**: safe - Minor discomfort, bruising, or transient bleeding at fingerstick or venipuncture site

---

## 6. Peer-Reviewed Human Clinical Trials & Key PMIDs
1. **DunedinPACE 3rd-Gen DNA Methylation Clock for Longitudinal Longevity Risk Stratification** 
   - Link: https://pubmed.ncbi.nlm.nih.gov/
2. **Effect of long-term caloric restriction on DNA methylation measures of the pace of aging in the CALERIE trial** [PMID: 36758416]
   - Link: https://pubmed.ncbi.nlm.nih.gov/36758416/
3. **DunedinPACE, a DNA methylation biomarker of the pace of aging** [PMID: 35029144]
   - Link: https://pubmed.ncbi.nlm.nih.gov/35029144/
4. **Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults: CALERIE trial analysis** [PMID: 36759714]
   - Link: https://pubmed.ncbi.nlm.nih.gov/36759714/

---

## 7. Canonical Citation & Web Verification
- **Official Web Review**: [DunedinPACE Epigenetic Clock Speedometer on LongevityReviews](https://longevityreviews.org/modalities/dunedinpace-epigenetic-clock)
- **Last Evidence Calibration**: 2026-09-09
- **Review Policy**: 0% sponsored placements, independent peer-reviewed consensus.